Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | Zhimeng |
Description | EXCELLENCE, INTEGRITY, Zhimeng Biopharma is a startup biotech founded in 2017 by seasoned pharmaceutical industry veterans. Located in the economy-vibrant and resource-rich Zhangjiang High-Tech Park of Shanghai, China, Zhimeng is developing medicines for the treatment of |
Keywords | Zhimeng Biopharma,挚盟 |
WebSite | core-biopharma.com |
Host IP | 47.92.230.99 |
Location | China |
Site | Rank |
US$680,974
Last updated: 2023-05-16 09:43:41
core-biopharma.com has Semrush global rank of 15,542,891. core-biopharma.com has an estimated worth of US$ 680,974, based on its estimated Ads revenue. core-biopharma.com receives approximately 78,574 unique visitors each day. Its web server is located in China, with IP address 47.92.230.99. According to SiteAdvisor, core-biopharma.com is safe to visit. |
Purchase/Sale Value | US$680,974 |
Daily Ads Revenue | US$629 |
Monthly Ads Revenue | US$18,858 |
Yearly Ads Revenue | US$226,293 |
Daily Unique Visitors | 5,239 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
core-biopharma.com. | A | 600 | IP: 47.92.230.99 |
core-biopharma.com. | NS | 21600 | NS Record: dns16.hichina.com. |
core-biopharma.com. | NS | 21600 | NS Record: dns15.hichina.com. |
Zhimeng Biopharma EN | 简体 Home About Us People Leadership Team Scientific Advisors Pipeline News Investors Join Us Contact --> EXCELLENCE, INTEGRITY, COMPASSION EXCELLENCE, INTEGRITY, COMPASSION Previous Next Our Mission Discover and develop the most effective, safe and affordable drugs to improve the quality of life of patients in China and abroad. Learn More © 2018 Copyright --> Quick Links About Us Contact Us Join Us Pipeline Leadership Team Management Team --> Scientific Advisors Recent News Zhimeng Biopharma Entered into A Global Exclusive Licensing Agreement with GlaxoSmithKline in HBV Zhimeng Biopharma Announces Dosing of First Subject in Phase II Clinical Trial of Its Novel HBV Capsid Assembly Modulator Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase I Clinical Trial of CB06 © 2023 Zhimeng Biopharma. |
HTTP/1.1 200 OK Server: nginx Date: Sat, 22 Jan 2022 09:04:13 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Vary: Accept-Encoding X-Powered-By: PHP/5.6.34 |
Domain Name: CORE-BIOPHARMA.COM Registry Domain ID: 2333219803_DOMAIN_COM-VRSN Registrar WHOIS Server: grs-whois.hichina.com Registrar URL: http://www.net.cn Updated Date: 2018-11-16T04:47:09Z Creation Date: 2018-11-16T04:41:17Z Registry Expiry Date: 2024-11-16T04:41:17Z Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd. Registrar IANA ID: 420 Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com Registrar Abuse Contact Phone: +86.95187 Domain Status: ok https://icann.org/epp#ok Name Server: DNS15.HICHINA.COM Name Server: DNS16.HICHINA.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-22T09:09:52Z <<< |